Rabeprazole Sodium
Product Images NDC 50090-1424
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 50090-1424). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image-02 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 02)
Image03 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 03)
Image-04 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 04)
Image05 (Bc740f24 4ae4 4526 Bb34 199d1bd917ff 05)
The text appears to be a table showing heartburn scores for a study involving two groups: Placebo (consisting of 58 participants) and RAB20mg (consisting of 59 participants). The scores are provided for different time periods, i.e., 7, 14, 21, and 28 days. The severity of the heartburn is rated on a scale of 1 to 4, where 1 is none, 2 is light, 3 is moderate, and 4 is very severe.*
Label Image (Lbl500901424)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.